Drug-Resistant Tuberculosis Among Children: A Systematic Review and Meta-Analysis

Background: Drug-resistant tuberculosis (DR-TB), especially multidrug-resistant tuberculosis (MDR-TB) is a public health threat. Little is known about estimates of different profiles and rates of DR-TB among children globally.Methods: We did a systematic review and meta-analysis of observational stu...

Full description

Bibliographic Details
Main Authors: Wan-mei Song, Yi-fan Li, Yun-xia Liu, Yao Liu, Chun-bao Yu, Jin-yue Liu, Huai-chen Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2021.721817/full
_version_ 1818433328585375744
author Wan-mei Song
Wan-mei Song
Yi-fan Li
Yun-xia Liu
Yao Liu
Chun-bao Yu
Jin-yue Liu
Huai-chen Li
Huai-chen Li
author_facet Wan-mei Song
Wan-mei Song
Yi-fan Li
Yun-xia Liu
Yao Liu
Chun-bao Yu
Jin-yue Liu
Huai-chen Li
Huai-chen Li
author_sort Wan-mei Song
collection DOAJ
description Background: Drug-resistant tuberculosis (DR-TB), especially multidrug-resistant tuberculosis (MDR-TB) is a public health threat. Little is known about estimates of different profiles and rates of DR-TB among children globally.Methods: We did a systematic review and meta-analysis of observational studies reporting DR-TB among children by searching Embase, PubMed, and Scopus databases from January 1, 2000 to October 1, 2020. Publications reporting more than 60 children with bacteriological confirmed tuberculosis and phenotypical drug susceptibility testing (DST) results were included. Pooled proportions of MDR-TB and sub-analysis by age subgroups, regions, economical levels were performed.Results: We identified 4,063 studies, of which 37 were included. Of 23,652 pediatric TB patients, the proportions of DR-TB, MDR-TB, mono-resistant TB, polydrug resistant TB, extensively drug-resistant TB were 13.59% (1,964/14,453), 3.72% (881/23,652), 6.07% (529/8,719), 1.61% (119/7,361), 0.44% (30/6,763), respectively. The pooled proportion of MDR-TB among 23,652 children of 37 studies was 3.7% (95% CI, 3.5–4.0%). Rate of MDR-TB was much lower in high-income countries (1.8%) than that in lower-middle-income countries (6.3%) and upper-middle-income countries (7.3%). More specifically, the rates of MDR-TB were 1.7% in USA, 1.7% in UK, 2.9% in India, 6.0% in South Africa, 9.8% in China, respectively.Conclusions: The burden of DR-TB remains high in children, and there are potential associations between rates of pediatric MDR-TB and national economical levels. More interventions on child TB cases in low-income countries may be urgently needed in future.
first_indexed 2024-12-14T16:19:21Z
format Article
id doaj.art-b08c067a602541ae84df5283d785e814
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-12-14T16:19:21Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-b08c067a602541ae84df5283d785e8142022-12-21T22:54:51ZengFrontiers Media S.A.Frontiers in Public Health2296-25652021-08-01910.3389/fpubh.2021.721817721817Drug-Resistant Tuberculosis Among Children: A Systematic Review and Meta-AnalysisWan-mei Song0Wan-mei Song1Yi-fan Li2Yun-xia Liu3Yao Liu4Chun-bao Yu5Jin-yue Liu6Huai-chen Li7Huai-chen Li8Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, ChinaCheeloo College of Medicine, Shandong University, Jinan, ChinaDepartment of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, ChinaDepartment of Biostatistics, School of Public Health, Shandong University, Jinan, ChinaDepartment of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, ChinaKatharine Hsu International Research Center of Human Infectious Diseases, Shandong Provincial Chest Hospital, Jinan, ChinaDepartment of Intensive Care Unit, Shandong Provincial Third Hospital, Jinan, ChinaDepartment of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, ChinaCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, ChinaBackground: Drug-resistant tuberculosis (DR-TB), especially multidrug-resistant tuberculosis (MDR-TB) is a public health threat. Little is known about estimates of different profiles and rates of DR-TB among children globally.Methods: We did a systematic review and meta-analysis of observational studies reporting DR-TB among children by searching Embase, PubMed, and Scopus databases from January 1, 2000 to October 1, 2020. Publications reporting more than 60 children with bacteriological confirmed tuberculosis and phenotypical drug susceptibility testing (DST) results were included. Pooled proportions of MDR-TB and sub-analysis by age subgroups, regions, economical levels were performed.Results: We identified 4,063 studies, of which 37 were included. Of 23,652 pediatric TB patients, the proportions of DR-TB, MDR-TB, mono-resistant TB, polydrug resistant TB, extensively drug-resistant TB were 13.59% (1,964/14,453), 3.72% (881/23,652), 6.07% (529/8,719), 1.61% (119/7,361), 0.44% (30/6,763), respectively. The pooled proportion of MDR-TB among 23,652 children of 37 studies was 3.7% (95% CI, 3.5–4.0%). Rate of MDR-TB was much lower in high-income countries (1.8%) than that in lower-middle-income countries (6.3%) and upper-middle-income countries (7.3%). More specifically, the rates of MDR-TB were 1.7% in USA, 1.7% in UK, 2.9% in India, 6.0% in South Africa, 9.8% in China, respectively.Conclusions: The burden of DR-TB remains high in children, and there are potential associations between rates of pediatric MDR-TB and national economical levels. More interventions on child TB cases in low-income countries may be urgently needed in future.https://www.frontiersin.org/articles/10.3389/fpubh.2021.721817/fulltuberculosischildrendrug resistancemeta-analysisnational economic levels
spellingShingle Wan-mei Song
Wan-mei Song
Yi-fan Li
Yun-xia Liu
Yao Liu
Chun-bao Yu
Jin-yue Liu
Huai-chen Li
Huai-chen Li
Drug-Resistant Tuberculosis Among Children: A Systematic Review and Meta-Analysis
Frontiers in Public Health
tuberculosis
children
drug resistance
meta-analysis
national economic levels
title Drug-Resistant Tuberculosis Among Children: A Systematic Review and Meta-Analysis
title_full Drug-Resistant Tuberculosis Among Children: A Systematic Review and Meta-Analysis
title_fullStr Drug-Resistant Tuberculosis Among Children: A Systematic Review and Meta-Analysis
title_full_unstemmed Drug-Resistant Tuberculosis Among Children: A Systematic Review and Meta-Analysis
title_short Drug-Resistant Tuberculosis Among Children: A Systematic Review and Meta-Analysis
title_sort drug resistant tuberculosis among children a systematic review and meta analysis
topic tuberculosis
children
drug resistance
meta-analysis
national economic levels
url https://www.frontiersin.org/articles/10.3389/fpubh.2021.721817/full
work_keys_str_mv AT wanmeisong drugresistanttuberculosisamongchildrenasystematicreviewandmetaanalysis
AT wanmeisong drugresistanttuberculosisamongchildrenasystematicreviewandmetaanalysis
AT yifanli drugresistanttuberculosisamongchildrenasystematicreviewandmetaanalysis
AT yunxialiu drugresistanttuberculosisamongchildrenasystematicreviewandmetaanalysis
AT yaoliu drugresistanttuberculosisamongchildrenasystematicreviewandmetaanalysis
AT chunbaoyu drugresistanttuberculosisamongchildrenasystematicreviewandmetaanalysis
AT jinyueliu drugresistanttuberculosisamongchildrenasystematicreviewandmetaanalysis
AT huaichenli drugresistanttuberculosisamongchildrenasystematicreviewandmetaanalysis
AT huaichenli drugresistanttuberculosisamongchildrenasystematicreviewandmetaanalysis